KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Free Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -15.48%
Dec 28, 2025 -4.86%
Sep 28, 2025 0.94%
Jun 29, 2025 0.32%
Mar 30, 2025 4.33%
Dec 29, 2024 0.89%
Sep 29, 2024 0.53%
Jun 30, 2024 -1.84%
Mar 31, 2024 -0.26%
Dec 31, 2023 4.96%
Oct 1, 2023 3.65%
Jul 2, 2023 -10.09%
Apr 2, 2023 -4.08%
Jan 1, 2023 -18.55%
Apr 3, 2022 7.46%
Apr 4, 2021 16.99%
Sep 27, 2020 7.40%
Jun 28, 2020 -9.93%
Mar 29, 2020 3.25%
Dec 29, 2019 10.58%
Sep 29, 2019 11.68%
Jun 30, 2019 1.73%
Mar 31, 2019 -2.60%
Dec 30, 2018 12.70%
Sep 30, 2018 1.20%
Jul 1, 2018 3.99%
Apr 1, 2018 11.76%
Dec 31, 2017 16.95%
Oct 1, 2017 4.96%
Jul 2, 2017 6.87%
Apr 2, 2017 0.52%
Jan 1, 2017 63.61%
Apr 3, 2016 -3.79%
Sep 27, 2015 3.50%
Jun 28, 2015 7.12%
Mar 29, 2015 -6.69%
Dec 28, 2014 -6.90%
Sep 28, 2014 -3.13%
Jun 29, 2014 10.91%
Mar 30, 2014 6.60%